Rabiner S F
Fed Proc. 1975 May;34(6):1454-7.
Stroma-free homoglobin solution has received extensive experimental trials in dogs and nonhuman primates. It has been shown to have no coagulant activity and to have no deleterious effect on renal function. Also pathological examination of autopsy and biopsy specimens fails to demonstrate any kidney damage after infusion of large amounts of stroma-free hemoglobin solution. In vivo data would also indicate that the solution can both carry oxygen and liberate it into tissues despite the fact that its in vitro oxygen dissociation curve is shifted to the left. Animals can be maintained with a 3% hematocrit after exchange transfusion with hemoglobin solution, without any significant fall in blood pressure or rise in central venous pressure. This is not true for nonoxygen carrying plasma expanders. Hemoglobin solution has also been shown to have an effect on blood rheology which would tend to increase flow through microcirculation. We conclude that stroma-free hemoglobin solution has potential for use as a plasma expander for treatment of hemorrhagic and possibly other types of shocks, as well as other uses.
无基质血红蛋白溶液已在犬类和非人类灵长类动物身上进行了广泛的实验。结果表明,它没有凝血活性,对肾功能也没有有害影响。此外,对尸检和活检标本的病理检查未能显示在输注大量无基质血红蛋白溶液后有任何肾脏损伤。体内数据还表明,尽管其体外氧解离曲线向左移动,但该溶液既能携带氧气,又能将氧气释放到组织中。在用血红蛋白溶液进行换血后,动物可以维持3%的血细胞比容,血压没有明显下降,中心静脉压也没有升高。对于非携氧血浆扩容剂来说并非如此。血红蛋白溶液还被证明对血液流变学有影响,这往往会增加微循环中的血流量。我们得出结论,无基质血红蛋白溶液有潜力用作血浆扩容剂,用于治疗出血性休克以及可能的其他类型休克,还有其他用途。